EUVIMEDEUVIMED entdecken
Crossref

Multi-omics analysis reveals metabolic reprogramming and CTH downregulation in diabetic kidney disease

Jiang Tan, Yuqin Chen, Jiliang Hu

Acta Diabetologica · 29.10.2026

DOI: 10.1007/s00592-026-02796-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Diabetologica, online erschienen am 29.10.2026. Verfasst von Jiang Tan und 2 weiteren Autor:innen. Beteiligte Einrichtung: College of Artificial Intelligence Medicine, Chongqing Medical University, No.1 of Yixueyuan Road, Yu Zhong District, Chongqing, 400016, People's Rep…. Die Arbeit nennt 20 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To characterize metabolic and transcriptional alterations in diabetic kidney disease (DKD) and identify diagnostic biomarkers using a multi-omics approach. Materials and methods Mendelian randomization (MR) was used to assess causal relationships between metabolites and DKD. Renal transcriptomic datasets validated pathway and gene alterations. Machine learning models evaluated diagnostic performance, with SHAP for interpretation. Single-cell and spatial transcriptomics defined cell-specific expression patterns. In silico gene perturbation and in vitro validation in high-glucose–treated HK-2 cells were conducted.

Results

MR analysis identified 60 plasma metabolites whose genetically predicted levels showed evidence of association with DKD. These metabolites were enriched in one-carbon metabolism, histidine metabolism, and glycine, serine, and threonine metabolism, which showed consistent alterations in renal transcriptomic analyses. Machine learning models showed strong diagnostic performance (mean AUC = 0.963), with MAOA, CTH, and ALDH1L1 as key contributors. CTH was specifically expressed in proximal tubular cells and downregulated in injury-associated subpopulations. Functional analyses indicated that CTH affected epithelial integrity, mitochondrial metabolism, and immune responses, and was suppressed under high-glucose conditions.

Conclusion

These findings provide insight into DKD pathogenesis and highlight CTH as a potential biomarker and therapeutic target.

Schlagwörter

Stichwörter der Autor:innen

Diabetic kidney diseaseMachine learningMendelian randomizationMetabolomics

Autor:innen und Institutionen

  • College of Artificial Intelligence Medicine, Chongqing Medical University, No.1 of Yixueyuan Road, Yu Zhong District, Chongqing, 400016, People's Republic of China.
  • Center for Neuroscience, College of Basic Medicine, Chongqing Medical University, Chongqing, People's Republic of China.
  • College of Artificial Intelligence Medicine, Chongqing Medical University, No.1 of Yixueyuan Road, Yu Zhong District, Chongqing, 400016, People's Republic of China. jlhu@cqmu.edu.cn.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Tan, J., Chen, Y., & Hu, J. (2026). Multi-omics analysis reveals metabolic reprogramming and CTH downregulation in diabetic kidney disease. Acta Diabetologica. https://doi.org/10.1007/s00592-026-02796-0

Vancouver

Tan J, Chen Y, Hu J. Multi-omics analysis reveals metabolic reprogramming and CTH downregulation in diabetic kidney disease. Acta Diabetologica. 2026. doi:10.1007/s00592-026-02796-0

BibTeX
@article{Tan2026,
  author = {Tan, Jiang and Chen, Yuqin and Hu, Jiliang},
  title = {Multi-omics analysis reveals metabolic reprogramming and CTH downregulation in diabetic kidney disease},
  journal = {Acta Diabetologica},
  year = {2026},
  doi = {10.1007/s00592-026-02796-0}
}
Kostenlos starten →